Post-Operative Pain Therapeutics Pipeline to Witness Many Technological Advancements in the Coming Years: P&S Market Research

NEW YORK, March 30, 2018 -- According to a new research report titled “Post-Operative Pain Therapeutics Pipeline Analysis, 2017” published by P&S Market Research, Post-operative pain currently exhibits a strong pipeline with 39 drug candidates.

Request for Sample Copy of this Research Report: https://www.psmarketresearch.com/market-analysis/post-operative-pain-therapeutics-pipeline-analysis/report-sample

The study analyzed that the post-operative pain therapeutics pipeline comprises approximately 39 drug candidates in different stages of development. Post-operative pain is one of the most common problem experienced by a person after any surgery. The intensity of pain can vary from acute to chronic depending upon the time it lasts. It starts when pain receptors activate an electrical signal that travels to the spinal cord. The spinal cord then transmits the signal to the brain. It involves the interaction of various chemicals, known as neurotransmitters, in the body, which together act to produce the sensation of pain in a person.

Innocoll Holdings plc is using CollaRx technology platform for the development of INL-001 for the treatment of post-operative pain. The CollaRx technology platform produces a lyophilized porous matrix of purified collagen that can be implanted at the time of surgery or applied topically to chronic or acute traumatic wounds. The CollaRx matrices are biodegradable and bio-resorbable. The in vivo release of drugs incorporated into the CollaRx matrix takes place via a combination of dissolution, diffusion and the interactive characteristics of the active drug and the formulation that can be modified to affect controlled release.

Browse Full Report with detailed TOC on “Post-Operative Pain Therapeutics Pipeline” at: https://www.psmarketresearch.com/market-analysis/post-operative-pain-therapeutics-pipeline-analysis

Some of the key players developing drugs for post-operative pain include DURECT Corporation, Elite Pharmaceuticals, Inc., Cara Therapeutics, Inc. and others.

More Reports Published by P&S Market Research

Sjögren’s Syndrome Therapeutics Pipeline Analysis - https://www.psmarketresearch.com/market-analysis/sjogrens-syndrome-therapeutics-pipeline-analysis

IgA Nephropathy Pipeline Analysis - https://www.psmarketresearch.com/market-analysis/iga-nephropathy-pipeline-analysis

About P&S Market Research

P&S Market Research is a market research company, which offers market research and consulting services for various geographies around the globe. We provide market research reports, industry forecasting reports, business intelligence, and research based consulting services across different industry/business verticals.

As one of the top growing market research agency, we’re keen upon providing market landscape and accurate forecasting. Our analysts and consultants are proficient with business intelligence and market analysis, through their interaction with leading companies of the concerned domain. We help our clients with B2B market research and assist them in identifying various windows of opportunity, and framing informed and customized business expansion strategies in different regions.

Contact:
P&S Market Research

347, 5th Ave. #1402

New York City, NY - 10016

Toll-free: +1-888-778-7886 (USA/Canada)

Email: [email protected]

Web: https://www.psmarketresearch.com

Connect with us: LinkedIn | Twitter | Google + | Facebook